Biotech Intelligence Platform
Turn Global Biotech Signals, Into Strategic Intelligence
Signal Overview
--
Total Signals
Indications Covered
--
Diseases
Recent High-Impact Signals
Top Signal This Week
The single most consequential move in biotech right now — curated by the INSILENS desk.
Deals & Financing
Novartis × Myricx Bio
M&AADC
Novartis Acquires Myricx Bio — Next-Generation ADC Payload Platform
Novartis agreed to acquire Myricx Bio for up to $1.5B, including $1.1B upfront, adding a novel NMT-inhibitor ADC payload platform — a signal that big pharma is now paying premium value for payload architecture, not just late-stage clinical assets.
Biotech Signals. Structured for Decisions.
INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.
July 9, 2026
July 9, 2026
July 8, 2026
July 9, 2026
July 9, 2026
June 24, 2026
InSilens by the Numbers
Platform at a Glance
Live coverage and community metrics, updated in real time.
Company Coverage
--
Companies Tracked
Platform Community
--
Registered Professionals
Indication Coverage
--
Diseases Tracked
Deals & Financing Tracker
--
Deals Tracked
